We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Seegene

Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App




SARS-CoV-2 RNA Test Assessed Among Recovered COVID-19 Patients

By LabMedica International staff writers
Posted on 25 Nov 2020
Some patients who have recovered from coronavirus disease 2019 (COVID-19) with documented negative real-time polymerase chain reaction (RT-PCR) results at the time of recovery have had subsequent positive RT-PCR test results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

In the absence of any symptoms suggestive of new SARS-CoV-2 infection and it is unknown whether such patients are infectious and whether they should be quarantined. More...
Real-time PCR is not a viral culture and does not allow determination of whether the virus is viable and transmissible.

A team of medical scientists associated with the Università Cattolica del Sacro Cuore (Rome, Italy) studied 176 recovered patients with COVID-19 who were admitted to the post-acute outpatient service of their institution from April 21 to June 18, 2020, for COVID-19 follow-up. Before that, patients had discontinued isolation according to current criteria which require no fever for three consecutive days, improvement in other symptoms, and two negative RT-PCR results for SARS-CoV-2 RNA 24 hours apart.

Nasal/oropharyngeal swab (NOS) samples from patients at follow-up were analyzed for total (genomic) and replicative (subgenomic) SARS-CoV-2 RNA using RT-PCR assays. Total SARS-CoV-2 RNA Detection and Quantification Total viral RNA was extracted from NOS samples using the Nimbus automated system (Seegene, Seoul, South Korea) which uses STARMag Universal Cartridge kit for both RNA extraction and PCR assay setup.

The RT-PCR testing was performed using the Seegene Allplex 2019-nCoV assay, a single-tube assay targeting three viral genes (E, RdRP, and N). Total viral RNA quantification was performed using the Quanty COVID-19 assay (Clonit S.r.l, Milan, Italy). Serum samples were tested with a commercial assay (Euroimmun; Lübeck, Germany), an enzyme-linked immunosorbent assay (ELISA) that uses the recombinant S1 domain of the SARS-CoV-2 spike (S) protein as antigen, for semi-quantitative detection of anti–SARS-CoV-2 IgG and IgA antibodies.

The investigators reported that 32 of 176 NOS samples (18.2%) tested positive for total SARS-CoV-2 RNA, with viral loads ranging from 1.6 × 101 to 1.3 × 104 SARS-CoV-2 RNA copies per mL. One of the 32 samples (3.1%) had replicative SARS-CoV-2 RNA. Samples from the 32 patients at the time of COVID-19 diagnosis were also tested and, expectedly, had replicative SARS-CoV-2 RNA. All but 1 of 32 patients had a positive serology result against SARS-CoV-2, as well as 139 of remaining 144 patients, at COVID-19 follow-up. The patient who tested serologically negative was not the one with a positive test result for replicative SARS-CoV-2 RNA. The mean ±SD time from COVID-19 diagnosis to follow-up was 48.6 ± 13.1 days in 32 patients and 57.7 ±16.9 days in 144 patients.

The authors concluded that their study highlights that many patients who recovered from COVID-19 may be still positive (albeit at lower levels) for SARS-CoV-2 RNA, but only a minority of the patients may carry a replicating SARS-CoV-2 in the respiratory tract. The study was published on November 12, 2020 in the journal JAMA Internal Medicine.

Related Links:
Università Cattolica del Sacro Cuore
Seegene
Clonit
Euroimmun


Gold Member
Serological Pipets
INTEGRA Serological Pipets
Collection and Transport System
PurSafe Plus®
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study has linked blood proteins to Alzheimer’s disease and memory loss (Photo courtesy of Shutterstock)

Blood Test Could Detect Proteins Linked to Alzheimer's Disease and Memory Loss

Alzheimer’s disease has long been associated with sticky amyloid plaques in the brain, but these markers alone do not fully explain the memory loss and cognitive decline patients experience.... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.